Clindamycin Hydrochloride — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

7 Recruiting

3 Completed trials

9 Sponsors

17 Countries

Phase III

Phase IV

Phase III: 4 Phase II: 1 Phase IV: 6

Indications tested

Hidradenitis 2 Implant site infection 1

Sponsors using this IMP

Novartis Pharma AG 2 UZ Leuven 2 Assistance Publique Hopitaux De Paris 1 Centre Hospitalier Et Universitaire De Limoges 1 Instituto De Investigacion Marques De Valdecilla 1 Region Hovedstaden 1 Region Midtjylland 1 University Medical Center Utrecht 1 Vaestra Goetalandsregionen 1

All trials

11 total

Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending

2024-518350-17-00 Phase IV 1 country Vaestra Goetalandsregionen
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
Rapid Oral Switch in Infectious Endocarditis, the ROSIE study Recruiting

2025-524484-20-00 Phase IV 1 country UZ Leuven
The DALBA-study Introduction of the antibiotic dalbavancin in orthopaedic surgery – an evaluation of: • Health economic costs • Patient-repo… Recruiting

2025-522088-13-00 Phase IV 1 country Region Midtjylland
Clindamycin for the treatment of infections: the influence of rifampicin and obesity on PK/PD target attainment Recruiting

2024-515872-12-00 Phase IV 1 country UZ Leuven
The PENTO protocol in Medication-Related Osteonecrosis of the Jaw (MRONJ) Recruiting

2024-518688-36-00 Phase II 1 country Centre Hospitalier Et Universitaire De Limoges
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Phase IV 4 countries University Medical Center Utrecht
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade… Ended

2024-513266-19-00 Phase III 10 countries Novartis Pharma AG
A Phase 3 study to assess efficacy, safety and tolerability of remibrutinib in adult and adolescent patients with moderate to severe hidrade… Ended

2024-513282-39-00 Phase III 9 countries Novartis Pharma AG
A randomized placebo-controlled double-blinded trial of the treatment of MRSA throat carriage with either standard decolonization therapy or… Ended

2024-516377-69-01 Phase IV 1 country Region Hovedstaden

Showing 1–11 of 11 trials

← All drugs A–Z